Comprehensive Analysis of Clinical Parameters That May Inform the Choice of Dose Regimen for Carfilzomib 20/27mg/m2 or 20/56mg/m2 With and Without Dexamethasone (20200381)

18/11/2020
23/04/2024
EU PAS number:
EUPAS37838
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

EUPAS37838-38139

English (1.27 MB - PDF) View document
Study results
Study results

20200381 Observational Research Study Report Abstract

English (110.2 KB - PDF) View document
Study report
Other information